Cardinal Health, Inc. (CAH) — Analyst outlook / Analyst consensus target is. Based on 33 analyst ratings, the consensus is bullish — 18 Buy, 15 Hold.
The consensus price target is $252.33 (low: $220.00, high: $275.00), representing an upside of 17.4% from the current price $214.95.
Analysts estimate Earnings Per Share (EPS) of $7.36 and revenue of $225.71B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $3.48 vs est $7.36 (missed -52.7%). 2025: actual $6.48 vs est $8.20 (missed -20.9%). Analyst accuracy: 31%.
CAH Stock — 12-Month Price Forecast
$252.33
▲ +17.39% Upside
Average Price Target
Based on 33 Wall Street analysts offering 12-month price targets for Cardinal Health, Inc., the average price target is $252.33, with a high forecast of $275.00, and a low forecast of $220.00.
The average price target represents a +17.39% change from the last price of $214.95.
Highest Price Target
$275.00
Average Price Target
$252.33
Lowest Price Target
$220.00
CAH Analyst Ratings
Buy
Based on 33 analysts giving stock ratings to Cardinal Health, Inc. in the past 3 months
EPS Estimates — CAH
31%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $3.48
vs Est $7.36
▼ 111.5% off
2025
Actual $6.48
vs Est $8.20
▼ 26.5% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — CAH
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $226.827B
vs Est $225.710B
▲ 0.5% off
2025
Actual $222.578B
vs Est $223.259B
▼ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
